Applied Dna Sciences Inc (NASDAQ:APDN) price on Thursday, March 20, fall -3.50% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.93.
A look at the stock’s price movement, the close in the last trading session was $2.00, moving within a range at $1.81 and $2.205. The beta value (5-Year monthly) was 0.421. Turning to its 52-week performance, $522.00 and $1.67 were the 52-week high and 52-week low respectively. Overall, APDN moved -76.42% over the past month.
Applied Dna Sciences Inc’s market cap currently stands at around $2.13 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-12.
Analysts have a consensus estimate of 1.19M for the company’s revenue for the quarter, with a low and high estimate of 1.19M and 1.19M respectively. The average forecast suggests up to a 27.47% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 5.28M, representing a 53.99% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that APDN is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend APDN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
APDN’s current price about -63.93% and -74.53% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 19.59, while 7-day volatility ratio is 24.80% and 15.17% in the 30-day chart. Further, Applied Dna Sciences Inc (APDN) has a beta value of 0.77, and an average true range (ATR) of 0.72. Analysts have given the company’s stock an average 52-week price target of $1.5, forecast between a low of $1.5 and high of $1.5. Looking at the price targets, the low is 22.28% off current price level while to achieve the yearly target high, price needs to move 22.28%. Nonetheless, investors will most likely welcome a 22.28% jump to $1.5 which is the analysts’ median price.
If we refocus on Applied Dna Sciences Inc (NASDAQ:APDN), historical trading data shows that trading volumes averaged 2.79 over the past 10 days and 282.85K over the past 3 months. The company’s latest data on shares outstanding shows there are 1.08 million shares.
The 6.82% of Applied Dna Sciences Inc’s shares are in the hands of company insiders while institutional holders own 39.58% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 60080.0 on 2025-02-28, giving us a short ratio of 1.58. The data shows that as of 2025-02-28 short interest in Applied Dna Sciences Inc (APDN) stood at 940.0 of shares outstanding, with shares short falling to 0.12 million registered in 2025-01-31. Current price change has pushed the stock -81.08% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the APDN stock continues to rise going into the next quarter.
